Cholesterol efflux

Cholesterol efflux refers to the process by which cells remove excess free cholesterol, exporting it primarily onto extracellular acceptors such as high-density lipoprotein (HDL) particles. This mechanism is critical for maintaining cellular lipid balance and preventing toxic accumulation of unesterified cholesterol within cells—especially macrophages in arterial walls. The main molecular mediators are ATP-binding cassette transporters like ABCA1 (which exports free cholesterol to lipid-poor apolipoproteins) and ABCG1 (which exports it mainly onto mature HDL), along with the scavenger receptor class B type I (SR-BI) that facilitates bidirectional transfer between cells and HDL. This process constitutes the first—and rate-limiting—step in reverse cholesterol transport, ultimately leading to hepatic excretion of sterols via bile. Impaired efficiency or regulation of this pathway contributes directly to cardiovascular diseases such as atherosclerosis, making its components important therapeutic targets but not "cholesterol efflux" itself—a biological function rather than an individual molecule or receptor.

Other names

Cellular cholesterol effluxHDL-mediated cholesterol effluxReverse cholesterol transport (first step)

Drugs targeting this process generally act by upregulating expression or activity of ABCA1, ABCG1, or SR-BI to enhance the removal of excess cellular cholesterol onto HDL particles for subsequent hepatic clearance.